Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Froehling

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of Thrombosis and Thrombolysis|January 7, 2022
Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcomeYumiko Hirao-Try, Danielle T Vlazny, Ryan Meverden, et al.
European Journal of Haematology|October 10, 2022
Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort studyEwa M Wysokinska, Damon E Houghton, Danielle T Vlazny, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosisDanielle T Vlazny, Ahmed K Pasha, Wiktoria Kuczmik, et al.
European Journal of Haematology|June 20, 2020
Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweightWaldemar E Wysokinski, David A Froehling, Damon E Houghton, et al.
Thrombosis Research|December 4, 2022
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolismWaldemar E Wysokinski, Damon E Houghton, Danielle T Vlazny, et al.
Mayo Clinic Proceedings|February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous ThromboembolismDalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Thrombosis and Thrombolysis|January 7, 2022
Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcomeYumiko Hirao-Try, Danielle T Vlazny, Ryan Meverden, et al.
European Journal of Haematology|October 10, 2022
Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort studyEwa M Wysokinska, Damon E Houghton, Danielle T Vlazny, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2021
Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosisDanielle T Vlazny, Ahmed K Pasha, Wiktoria Kuczmik, et al.
European Journal of Haematology|June 20, 2020
Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweightWaldemar E Wysokinski, David A Froehling, Damon E Houghton, et al.
Thrombosis Research|December 4, 2022
Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolismWaldemar E Wysokinski, Damon E Houghton, Danielle T Vlazny, et al.
Mayo Clinic Proceedings|February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous ThromboembolismDalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Pageof 3